Virginia Innovation Partnership Authority (309)
| Request Title | COVID-19 Drug Research and Development (2020 Special Session General Assembly Action - 135 #3c) |
| Biennium | 2020-2022 |
| Budget Round | Amended Bill |
| Category | General Assembly Action |
| Region | None |
Description
|
This amendment provides $5 million in the first year from the nongeneral fund to accelerate the research and development of therapeutic drug treatments for COVID-19. |
Funding Summary
| Object Type | FY 2020 | FY 2021 | |
| General Fund Dollars | $0 | $0 | |
| Nongeneral Fund Dollars | $5,000,000 | $0 | |
| General Fund Positions | 0.00 | 0.00 | |
| Nongeneral Positions | 0.00 | 0.00 | |
| General Fund Transfers | $0 | $0 | |
| General Fund Revenue | $0 | $0 | |
| Layoffs | $0 | $0 | |
| Additions to Balance | $0 | $0 |
Funding Details
| By Program | Program Code | Program Title | FY 2020 | FY 2021 |
| 534 | Economic Development Services | $5,000,000 | $0 | |
| By Fund | Fund Code | Fund Title | FY 2020 | FY 2021 |
| 02998 | Special Fund - Budgetary Only | $5,000,000 | $0 |
Authorized Position Details
| By Program | Program Code | Program Title | FY 2020 | FY 2021 |
p3_opview - Official Enacted Budget View Operating Bullet Details - 11-03-2025 21:18:28
